News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
07 07 2022 Qualified uninsured individuals now have access to the company's COVID-19 molecular diagnostic testing at approximately 1,200 Quest Diagnostics patient service centers SECAUCUS, N.J., July 7, 2022...
-
06 24 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2022 financial results on Thursday, July...
-
06 14 2022 Leading Patient Engagement Platform Honored in Digital Therapeutics and Mental Health Category BIRMINGHAM, Ala., June 14, 2022 /PRNewswire/ -- Leading patient engagement platform Pack Health, a...
-
06 13 2022 Nationally representative study of more than 5 million pregnant people finds those with Medicaid less likely to be screened than those with commercial insurance, demonstrating disparities in...
06 09 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sam Samad will become Executive Vice President and Chief Financial Officer. He...
-
06 06 2022 Analysis shows participants who stayed in the program at least 6 months reduced their diabetes drug costs by 18% In 2 oral and 3 poster presentations, Quest researchers also provided insights into...
-
05 31 2022 ConferMED, one of the nation's leading eConsult companies, has been awarded a $2.3M grant from the Quest Diagnostics Foundation. The grant will enable ConferMED to enhance its eConsults platform...
-
05 26 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Healthcare Conference. Steve...
05 25 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Cecilia McKenney, Senior Vice President and Chief Human Resources Officer (CHRO),...
-
05 17 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
-
05 11 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS 2022 Global Healthcare Conference....
-
05 09 2022 "2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health...
-
05 02 2022 Blood Test for Early Detection of Alzheimer's Disease (AD) Risk Will Lead to Better Patient Care, Physicians Say; U.S. Adults Call for Earlier Evaluation and More Education Quest Introduces Widely...
-
04 21 2022 First quarter revenues of $2.61 billion, down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92, down 15.6% from 2021; and adjusted diluted EPS of $3.22, down 14.4%...
-
04 20 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has made several organizational changes and leadership appointments of seasoned...
-
04 04 2022 New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Site Builds on Quest's Extended Care Services to Improve...
-
03 30 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2022 financial results on Thursday, April...
03 30 2022 Positivity for Cocaine and Marijuana Increase for Federally Mandated, Safety-Sensitive Workers Required to Test Under Federal Law Amid Widespread Recruiting and Retention Challenges, Drug...
-
03 23 2022 Quest to employ its comprehensive menu of COVID-19 antibody test and data analytics services to support population health research across 45 states and Puerto Rico SECAUCUS, N.J., March 23, 2022...
03 15 2022 The Quest Diagnostics Foundation today announced a $500,000 donation to Project HOPE to support its humanitarian crisis relief efforts in Ukraine and for Ukrainian refugees in Eastern Europe....
-
02 22 2022 At Quest Diagnostics, our vision is “Empowering better health with diagnostic insights.” Our goal is to make this a healthier world – not just for some, but for all. As we near the two-year...
02 15 2022 Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three statesBronx, N.Y./Secaucus, N.J, Feb. 15, 2022: Green Bronx Machine, a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences, today...
-
02 03 2022 -- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive ChairmanQuest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its Board of Directors, as part of its ongoing leadership succession planning,...
-
02 03 2022 - Full year revenues of $10.79 billion, up 14.3% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
-
02 02 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022...
-
01 31 2022 Convenient, physician-guided medical insights help people manage health without a trip to the doctor's officeQuest Diagnostics (NYSE: DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to...
-
01 28 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a score of 100% on the Human Rights Campaign Foundation's 2022...
-
01 26 2022 The ELF™ Test is the first and only prognostic blood test granted De Novo marketing authorization to assess disease progression in NASH patients. The ELF Test is now available nationwide through collaborations with Labcorp and Quest Diagnostics.TARRYTOWN, N.Y.--(BUSINESS WIRE)--The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive...
-
01 26 2022 Quest Diagnostics to Support COVID-19 Testing for Illinois and Texas Long-Term Care Facilities’ Residents, StaffWASHINGTON, DC (Jan. 26, 2022) - Project HOPE, a global health and humanitarian organization, is pleased to announce that Quest Diagnostics (NYSE: DGX), the world’s leading provider of...
-
01 26 2022 Individuals may perform test in minutes in the comfort of their home, at their convenienceQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of an at-home COVID-19 rapid antigen test service for consumer...
-
01 19 2022 First-of-Its Kind Service Includes Robust Selection of Diagnostic Tests, Customizable for Men and Women, with Biometric Screening and a Health Risk Assessment to Provide a Health Quotient Score That Can Be Tracked Over TimeAdults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the...
-
01 18 2022 Acquisition adds new capability in "Extended Care" services focused on engaging patients beyond traditional healthcare settings to improve outcomes and lower costsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement to acquire Pack Health in an...
-
01 12 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the fourth quarter and full year...
-
01 11 2022 Quest Diagnostics to Release Fourth Quarter and Full Year 2021 Financial Results on February 3, 2022Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2021 financial results on...
-
01 04 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 40th Annual J.P. Morgan Healthcare...
12 16 2021 Junior Achievement of New Jersey (JANJ) virtually held its 19th annual New Jersey Business Hall of Fame™ on Thursday, December 9, 2021. The 2021 Laureates included John E. Harmon, Sr., IOM,...
-
12 16 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2021 Workplace...
-
12 14 2021 Acquisition to broaden physicians' access to diagnostic services and deepen company's presence in the SoutheastQuest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has acquired substantially all assets of Labtech Diagnostics, an independent...
-
12 01 2021 Targeted Lung Panel Now Available with Physician's Order at Quest's 2,200 Patient Service Centers NationwidePhysicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics (NYSE: DGX), the nation's leading provider of...
-
11 17 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
-
11 15 2021 First-of-its-kind study reveals nearly three in four physicians believe telehealth visits limit the ability to determine if patients are at risk for or are already misusing prescription drugsA new Health Trends® report from Quest Diagnostics (NYSE: DGX) finds that almost 70% of physicians fear they missed signs of drug misuse during the pandemic, and, given how the global health...
-
11 08 2021 SECAUCUS, N.J., (DATE) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized as one of the World's Best Employers of...
-
11 04 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 30th Annual Healthcare...
-
11 04 2021 For the last twenty months, 50,000 Quest colleagues have given their all every day to support our nation through the COVID-19 crisis. The experience has shown the character of our company—and...
-
11 02 2021 Professional development program strives to eliminate health disparities among underserved populations by cultivating a pipeline of minority scholars for leadership roles in healthcareKANSAS CITY, MO, NOVEMBER 2, 2021 — The Bluford Healthcare Leadership Institute (BHLI), committed to eliminating health disparities among minority and vulnerable populations, recently hosted its...
-
10 21 2021 - Third quarter revenues of $2.77 billion, down 0.4% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2021. "We...
-
10 20 2021 Over 1,150 school districts in Texas can elect to participate in the testing programQuest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced it has formed an agreement with the Texas Department of State Health Services (DSHS)...
-
10 18 2021 As the First Laboratory to Validate Ki-67 IHC MIB-1 pharmDx (Dako Omnis), Quest Plans to Make Testing Available Nationally by the End of OctoberQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx...
10 12 2021 Advanced Technology and Automation Delivers Quality Lab Results to Physicians and Patients in Seven StatesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, has completed its integration of Northeast regional operations to its new 250,000 sq....
-
10 07 2021 Quest Diagnostics makes more than $3 million commitment to American Heart Association efforts to expand research and mentorship opportunities for Black and Hispanic scholars, and drive hypertension management and COVID-19 reliefDALLAS, October 7, 2021 — The American Heart Association (AHA), the leading public health nonprofit devoted to a world of healthier lives for all -- through a significant commitment from Quest...